Teyi Pharmaceutical Group Co.,Ltd reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 164.61 million compared to CNY 304.16 million a year ago. Revenue was CNY 164.61 million compared to CNY 304.16 million a year ago.

Net income was CNY 9.15 million compared to CNY 105.47 million a year ago. Basic earnings per share from continuing operations was CNY 0.0214 compared to CNY 0.2357 a year ago. Diluted earnings per share from continuing operations was CNY 0.0214 compared to CNY 0.2286 a year ago.